key: cord-0691162-hi20dohf authors: Roy, Sawrab; Sharma, Binayok; Mazid, Md. Ishtiaque; Akhand, Rubaiat Nazneen; Das, Moumita; Marufatuzzahan; Chowdhury, Tanjia Afrin; Azim, Kazi Faizul; Hasan, Mahmudul title: Identification and Host Response Interaction Study of SARS-CoV-2 encoded miRNA-Like Sequences: An in silico Approach date: 2021-04-27 journal: Comput Biol Med DOI: 10.1016/j.compbiomed.2021.104451 sha: 28633651bfe4fd1d56889e2e3c53e6f0ff95f712 doc_id: 691162 cord_uid: hi20dohf COVID-19, a global pandemic caused by an RNA virus named SARS-CoV-2 has brought the world to a standstill in terms of infectivity, casualty, and commercial plummet. RNA viruses can encode microRNAs (miRNAs) capable of modulating host gene expression, and with that notion, we aimed to predict viral miRNA like sequences of MERS-CoV, SARS-CoV and SARS-CoV-2, analyze sequence reciprocity and investigate SARS-CoV-2 encoded potential miRNA-human genes interaction using bioinformatics tools. In this study, we retrieved 206 SARS-CoV-2 genomes, executed phylogenetic analysis, and the selected reference genome (MT434792.1) exhibited about 99% similarities among the retrieved genomes. We predicted 402, 137, and 85 putative miRNAs of MERS-CoV (NC_019843.3), SARS-CoV (NC_004718.3), and SARS-CoV-2 (MT434792.1) genome, respectively. Sequence similarity was analyzed among 624 miRNAs and found that predicted miRNAs of SARS-CoV-2 share a cluster with the clad of miRNAs from MERS-CoV and SARS-CoV. Only SARS-CoV-2 derived 85 miRNAs were encountered for target prediction and 29 viral miRNAs seemed to target 119 human genes. Moreover, the Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) analysis suggested the involvement of respective genes in various pathways and biological processes. Finally, we focused on eight putative miRNAs influencing 14 genes that are involved in the adaptive hypoxic response, neuroinvasion and hormonal regulation, and tumorigenic progression in patients with COVID-19. SARS-CoV-2 encoded miRNAs may cause misexpression of some critical regulators and facilitate viral neuroinvasion, altered hormonal axis, and tumorigenic events in the human host. However, these propositions need validation from future studies. The Corona Virus Disease-2019 (COVID-19) has emerged as a public health emergency with a vast number of cases and death tolls. It has reached the magnitude of a 'Global Pandemic' with 216 countries held captive by its atrocious clinicopathological consequences, loss of productivity and gross economic downfall (1-3). This highly contagious zoonotic disease is caused by a single-strand, enveloped RNA virus native to the 'Coronaviridae' family that genetically resembles severe acute respiratory syndrome coronavirus (SARS-CoV) of 2002-2003, and hence nominated as SARS-CoV-2 (4) (5) (6) (7) (8) (9) . COVID-19 is transmissible via direct contact, fomites or aerosol droplets generated from spitting, sneezing or coughing by an infected person (10) . After entry into the host, the median time for incubation is an estimated 4-5 days extending up to 14 days (11) (12) (13) . Clinically, SARS-CoV-2 manifests a number of symptoms such as fever, fatigue, malaise, headache coupled with pneumonia or acute respiratory distress syndrome (ARDS) (14) . Although the initial infection harbors in the lungs, it may develop viremia with a risk of multisystem involvement leading to septicemia and organ failure (15-17). Extra-pulmonary conditions include neurologic involvement (stroke, loss of smell or taste), cardiovascular symptoms (myocardial dysfunction, arrhythmia, acute coronary syndromes), renal damage (acute kidney injury), gastrointestinal distress (nausea, vomiting, diarrhea, loss of appetite), hepatocellular injury and metabolic derangements (hyperglycemia and ketosis) (18-21). Immuno-compromised individuals with coexisting illnesses for instance, cardiovascular disease, hypertension, diabetes, asthma, malignancy and chronic diseases are the highest vulnerable cohort for COVID-19 (22,23). Studies have reported higher mortality rates in aged and male J o u r n a l P r e -p r o o f patients (>60 years; Male:Female = 1.7:1) with additional comorbidities such as cardiovascular disease (13.2%), diabetes (9.2%) and hypertension (8.4%) (19,24). In recent years, microRNAs (miRNAs) have gained much attention as a post-transcriptional regulatory molecule leading to pathogenicity of disease (25). These are minuscule non-proteincoding endogenous RNA molecules, capable of regulating approximately 50% of all mammalian protein-coding genes involved in various pathophysiologic mechanisms in eukaryotic organisms (38) . Different miRNAs can also target multiple sites on a single transcript (39, 40) . However, if the viral miRNAs target in imperfect complementarity, that results in translational repression and mRNA destabilization (41, 42) . Hence, RNA viruses can use the miRNA biogenesis pathway to produce modulatory molecules for mRNA manipulation (43) . Viral miRNAs can regulate the interaction with different biological processes comprising metabolism, growth, apoptosis, differentiation, proliferation and angiogenesis (44) (45) (46) , and take part in replication, inhibition, pathogenesis and disease progression via genomic binding or interfering in host transcriptome activities (47) (48) (49) . Previous research has hinted towards miRNAs to have a role in the development of stroke, cardiovascular disease, inborn errors of metabolism, endocrine J o u r n a l P r e -p r o o f disorders, metabolic disease, autoimmune disease, neurodegenerative ailment, retinal disorder and carcinoma (50) (51) (52) (53) (54) . Prior literature has delved into the role of viral miRNAs in fetal developmental anomalies due to the Zika virus (55) , dampening of cell-mediated immunity by the Ebola virus (32), enhanced cytokine signaling by influenza virus (36). Post-COVID-19 computational studies have focused on prediction of mature viral miRNA, their functions, exchanges between viral miRNA-cellular gene, and the impact of aging and health conditions on such interactions (56) (57) (58) (59) . Following the trend, we performed an in silico analysis to predict the putative miRNAs of SARS-CoV-2 and their targeted host genes. Moreover, we aim to explore possible host-virus interactions to gain further insight into the viral pathogenicity and correlate the findings with current clinical data. J o u r n a l P r e -p r o o f Vmir (an ab initio program) algorithm was used to predict pre-miRNAs of MERS-CoV, SARS-CoV and SARS-CoV-2 fasta sequences by setting strict cutoff parameters (minimal window count: 35, a hairpin length value: 50 to 220, and window size: 500 and step size: 1), as described by other literature (55, (63) (64) (65) . The correspondences were then inputted to the miRNA fold algorithm as multi-fasta format for the strict-efficient prediction of hairpin structure (66) , and further validated by ViralmiR, (a support vector machine) (67). The potential pre-miRNAs were submitted to Mfold (a web server algorithm) to predict the MatureBayes, a Naïve Bayes classifier, was used to identify the potential mature miRNA:miRNA* duplexes from the predicted viral microRNA precursors (69) , and extract the duplex 5′ stem mature miRNA like sequences because of their interaction with the 3′ UTR of human mRNAs (70, 71 MiRDB, the Perl script implementing the MirTarget algorithm, was performed to predict potential targets in 3'-UTR or coding region of human mRNAs (73, 74) . Mature miRNA transcripts were employed to the miRDB custom-target prediction to identify viral miRNAs targeting humans. Gene symbols and Uniprot gene IDs of the targeted genes were extracted from UniProtKB. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG; https://www.genome.jp/kegg/) signaling pathway analyses were performed to extract the biological theme of the listed viral miRNA targeted human genes using the Database for Annotation, Visualization, and Integrated Discovery (DAVID) v6.8 (https://david.ncifcrf.gov/). Table 1 shows significant steps involved in the prediction of SARS-CoV-2 encoded miRNAs and its target in human, along with used bioinformatics tools and outputs. In our study, we retrieved 206 SARS-CoV-2 genomes based on available data regarding different We used SARS-CoV-2 encoded 85 miRNAs in MiRDB for target prediction in humans. A total of 119 human genes are identified that seem to be targeted by the 29 viral miRNAs (Supplementary Table 1 ). All targeted human genes have the target score of 100 that indicates maximum confidence in the prediction. In our study, we used DAVID software to analyze the functional annotation of the viral miRNAtargeted human genes (the result is available in Supplementary file 6). Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway annotation and GO analysis were employed to identify the biological theme of the viral miRNAs targeting human genes. KEGG annotation analysis data identified that these miRNAs have influenced genes in the thyroid hormone signaling pathway (6 genes), Hippo signaling pathway (6 genes), renal cell carcinoma (4 genes), pathway in cancer (7 genes), proteoglycans in cancer (5 genes) and the number of other signaling pathways ( Figure 4 ). GO analysis found that SARS-CoV-2 miRNAs targeted human genes are significantly associated with 37 biological processes, eight cellular components, and 13 molecular functions based on the relative P value ( Figure 5 ). We have attempted to validate our findings with the gene expression profile of COVID-19 patients from published literature ( Table 2 ). We searched for alignments of predicted miRNA sequences in the raw RNA-seq dataset (Table 3) . Death in patients with COVID-19 is associated with age, gender, and comorbidities (141) . Besides, those who recover may have to deal with future clinical consequences of which, cancer can be a particular concern (142). It is thought-provoking whether COVID-19 can set towards tumorigenesis via a complex dysregulation of the oncogenes-miRNA-tumor suppressor genes (TSGs) network, induced by some genetic and epigenetic factors (143) . KEGG pathway analysis in this study has identified HIF1A, TGFB2, ETS1, CTNNB1, IGF2, CRKL, BCL2 genes to have regulatory roles in constituting proteoglycans, activating pathways in cancer, involvement in colorectal and renal cell carcinoma. COVID-19 hypoxia creates an interior milieu that can favor HIF1A driven HIF cell signaling involved in blood vessel formation, epithelial to mesenchymal transition, cell mobility, and metastasis (144) (145) (146) (147) . Defects in TGFB2 and ETS1 pathways can lead to the opening of multiple oncogenic pathways, such as evasion of host immune surveillance, stem cell development, sustained angiogenesis, and loss of apoptotic control, aberrant cellular proliferation, epithelial-to-mesenchymal transition, and metastasis (148) (149) (150) (151) . Mutations of CTNNB1 genes alter the typical 3D structure of the β-catenin protein, leading to uncontrolled cell proliferation, immunosuppression, disrupted metabolic regulation (152) . Previous studies have associated the role of CRKL in epithelial cell migration and invasion to aid in metastasis (153, 154) . Elevated IGF2 expression has a propensity for heightening the risk of developing breast, prostate, lung, and colorectal cancers (155, 156) . Deregulation of BCL2 J o u r n a l P r e -p r o o f expression deviates mitochondrial apoptotic machinery to cause tumorigenesis and therapeutic resistance in several human malignancies (157, 158) . In the context of COVID-19, a complex interplay between these genes, viral miRNAs coupled with environmental factors and host defenses, could potentially initiate tumorigenesis in an infected patient. However, whether or to what extent SARS-CoV-2 viral miRNAs have involvement in the development and progression of tumor and cancer in human hosts by misexpression of some vital regulators is a matter best left for future genomic and experimental studies to validate. Since This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Overexpression (76) • Timeline of WHO's response to COVID-19 World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19) The socio-economic implications of the coronavirus pandemic (COVID-19): A review Coronavirus disease 2019 (COVID-19): A literature review Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19) A pneumonia outbreak associated with a new coronavirus of probable bat origin Viral Metagenomics Revealed Sendai Virus and Coronavirus Infection of Malayan Pangolins (Manis javanica) COVID-19, SARS and MERS: are they closely related? Turbulent Gas Clouds and Respiratory Pathogen Emissions: Potential Implications for Reducing Transmission of COVID-19 Clinical characteristics of coronavirus disease 2019 in China Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming Identification of Cellular Genes Targeted by KSHV-Encoded MicroRNAs The impact of microRNAs on protein output Widespread changes in protein synthesis induced by microRNAs Functional microRNA generated from a cytoplasmic RNA virus State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia Circulating microRNAs as Potential Diagnostic Biomarkers and Therapeutic Targets in Gastric Cancer: Current Status and Future Perspectives Circulating microRNA-192 as a diagnostic biomarker in human chronic lymphocytic leukemia MicroRNA Regulation of RNA Virus Replication and Pathogenesis MiR-342-5p suppresses coxsackievirus B3 biosynthesis by targeting the 2C-coding region Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex miRNA-based strategy for modulation of influenza A virus infection Editorial: MicroRNAs as new players in endocrinology MiRNA Biogenesis and Regulation of Diseases: An Overview Meta-regulation: microRNA regulation of glucose and lipid metabolism The role of microRNAs in the pathogenesis of autoimmune diseases In silico analysis revealed Zika virus miRNAs associated with viral pathogenesis through alteration of host genes involved in immune response and neurological functions Computational analysis of microRNA-mediated interactions in SARS-CoV-2 infection Virulence in Aged Patients Might Be Impacted by the Host Cellular MicroRNAs Abundance/Profile. Aging Dis The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities The miRNA Complexes Against Coronaviruses COVID-19 MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies PartitionFinder 2: New Methods for Selecting Partitioned Models of Evolution for Molecular and Morphological Phylogenetic Analyses Computational prediction of viral miRNAs A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses West Nile virus encodes a microRNA-like small RNA in the 3′ untranslated region which up-regulates GATA4 mRNA and facilitates virus replication in mosquito cells miRNAFold: a web server for fast miRNA precursor prediction in genomes ViralmiR: a support-vector-machine-based method for predicting viral microRNA precursors Evidence that miRNAs are different from other RNAs MatureBayes: A Probabilistic Algorithm for Identifying the Mature miRNA within Novel Precursors Pairing beyond the Seed Supports MicroRNA Targeting Specificity New Algorithms and Methods to Estimate Maximum-Likelihood Phylogenies: Assessing the Performance of PhyML 3.0 miRDB: an online database for prediction of functional microRNA targets miRDB: an online resource for microRNA target prediction and functional annotations Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients MicroRNome Analysis Unravels the Molecular Basis of SARS Infection in Bronchoalveolar Stem Cells The phylogenetic utility and functional constraint of microRNA flanking sequences The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system Elevated plasma levels of selective cytokines in COVID-19 patients reflect viral load and lung injury Endothelial cell infection and endotheliitis in COVID-19 COVID-19 and its implications for thrombosis and anticoagulation COVID-19 pneumonia: ARDS or not? Hypoxic Pulmonary Vasoconstriction Oxygen sensing in the hypoxic response pathway: regulation of the hypoxiainducible transcription factor Targeting HIF-1 for cancer therapy Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics Hypoxia-Inducible Factors in Physiology and Medicine Hypoxia-Induced Angiogenesis: Good and Evil Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19 Erythropoietin stimulates phosphorylation and activation of GATA-1 via the PI3-kinase/AKT signaling pathway A Novel Mechanism of Cooperation between c-Kit and Erythropoietin Receptor Hypoxia-inducible factor 1-mediated human GATA1 induction promotes erythroid differentiation under hypoxic conditions Regulation of erythropoiesis by hypoxia-inducible factors Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study COVID-19: Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients Erythropoietin as candidate for supportive treatment of severe COVID-19 Does recombinant human erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects COVID-19 with silent hypoxemia COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19? The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients Apoptosis and Necroptosis as Host Defense Strategies to Prevent Viral Infection To kill or be killed: viral evasion of apoptosis Structural biology of the Bcl-2 family of proteins Hepatitis C Virus Nonstructural 5A Protein Inhibits Lipopolysaccharide-Mediated Apoptosis of Hepatocytes by Decreasing Expression of Toll-Like Receptor 4 RSV P-protein impairs extrinsic apoptosis pathway in a macrophage-like cell line persistently infected with respiratory syncytial virus Mechanisms Controlling Mitochondrial Biogenesis and Respiration through the Thermogenic Coactivator PGC-1 Peroxisome proliferator-activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres Complementary action of the PGC-1 coactivators in mitochondrial biogenesis and brown fat differentiation Roles of Oxidative Stress, Apoptosis, PGC-1α and Mitochondrial Biogenesis in Cerebral Ischemia The Role of PGC-1α in the Pathogenesis of Neurodegenerative Disorders Coronavirus infection of rat dorsal root ganglia: Ultrastructural characterization of viral replication, transfer, and the early response of satellite cells Neurotropic virus tracing suggests a membranous-coating-mediated mechanism for transsynaptic communication Immunofluorescence studies on the pathogenesis of hemagglutinating encephalomyelitis virus infection in pigs after oronasal inoculation The Vagus Nerve is One Route of Transneural Invasion for Intranasally Inoculated Influenza A Virus in Mice Axonal Transport Enables Neuron-to-Neuron Propagation of Human Coronavirus OC43 Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms Is the Collapse of the Respiratory Center in the Brain Responsible for Respiratory Breakdown in COVID-19 Patients? An official American thoracic society statement: Update on the mechanisms, assessment, and management of dyspnea Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity Dlx1 and Dlx2 Control Neuronal versus Oligodendroglial Cell Fate Acquisition in the Developing Forebrain The PROK2/PROKR2 signaling pathway is required for the migration of most olfactory bulb interneurons Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease Potential pathogenesis of ageusia and anosmia in COVID-19 patients Circadian Rhythms and Hormonal Homeostasis: Pathophysiological Implications Modulation of Estrogen Receptor-α Transcriptional Activity by the Coactivator PGC-1 Estrogen Signals Through Peroxisome Proliferator-Activated Receptor−γ Coactivator 1α to Reduce Oxidative Damage Associated With Diet-Induced Fatty Liver Disease 17ß-Estradiol Antagonizes the Down-Regulation of ERα/NOS-3 Signaling in Vascular Endothelial Dysfunction of Female Diabetic Rats Estradiol Stimulates Vasodilatory and Metabolic Pathways in Cultured Human Endothelial Cells 17β-Estradiol Regulation of Human Endothelial Cell Basal Nitric Oxide Release, Independent of Cytosolic Ca 2+ Mobilization 17β-estradiol inhibits apoptosis of endothelial cells Prevention and therapy of COVID-19 via exogenous estrogen treatment for both male and female patients Inflammation and cancer COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study Clinical sequelae of the novel coronavirus: does COVID-19 infection predispose patients to cancer? New Insight into microRNA Functions in Cancer: Oncogene-microRNA-Tumor Suppressor Gene Network The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy HIF1A Overexpression Is Associated with Poor Prognosis in a Cohort of 731 Colorectal Cancers Antisense Long Noncoding RNA HIF1A-AS2 Is Upregulated in Gastric Cancer and Associated with Poor Prognosis HIF1A-AS2 predicts poor prognosis and regulates cell migration and invasion in triple-negative breast cancer TGF- : Duality of Function Between Tumor Prevention and Carcinogenesis The role of the transcription factor Ets1 in carcinoma The ETS family of oncogenic transcription factors in solid tumours Evaluation of zinc finger E-box binding homeobox 1 and transforming growth factor-beta2 expression in bladder cancer tissue in comparison with healthy adjacent tissue Exon 3 mutations of CTNNB1 drive tumorigenesis: a review Crk family adaptors-signalling complex formation and biological roles Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer Insulin-like growth factor 2 (IGF2) signaling in colorectal cancer-from basic research to potential clinical applications BCL2-family dysregulation in B-cell malignancies: From gene expression regulation to a targeted therapy biomarker Bcl-2 family proteins in breast development and cancer: could Mcl-1 targeting overcome therapeutic resistance? Gene expression and DNA methylation analyses suggest that immune process-related ADCY6 is a prognostic factor of luminal-like breast cancer The authors declare that they do not have any known competing financial interests or personal relationships that could influence the work reported in this paper. All data generated and analyzed during this study are included in the main manuscript or supplementary files.